St. Jude Resumes Portico TAVR Sales In Europe
This article was originally published in The Gray Sheet
Executive Summary
The CE mark for St. Jude’s Portico transcatheter aortic valve has been restored and the company is working with FDA to resume the U.S. IDE trial following a six-month pause to study a possible leaflet motion issue observed in the U.S. trial.